ciltacabtagene autoleucel
janssen
['cartitude-2', 'cilta-cel', 'mmsm']
niels van de donk, md, phd, professor at amsterdam university medical centers, discussed positive findings from cohort b of the cartitude-2 study, including a 100% orr in patients with early relapsed mm treated with cilta-cel. #asco22 #mmsm 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.